0000930413-12-000229.txt : 20120119 0000930413-12-000229.hdr.sgml : 20120119 20120119184545 ACCESSION NUMBER: 0000930413-12-000229 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120117 FILED AS OF DATE: 20120119 DATE AS OF CHANGE: 20120119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Conover Charles CENTRAL INDEX KEY: 0001538563 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12957 FILM NUMBER: 12535573 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD CITY: PISCATAWAY STATE: NJ ZIP: 08854 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZON PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000727510 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222372868 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 BUSINESS PHONE: 732-980-4500 MAIL ADDRESS: STREET 1: 20 KINGSBRIDGE ROAD STREET 2: ATT: GENERAL COUNSEL CITY: PISCATAWAY STATE: NJ ZIP: 08854 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICALS INC DATE OF NAME CHANGE: 20021211 FORMER COMPANY: FORMER CONFORMED NAME: ENZON PHARMACEUTICAL INC DATE OF NAME CHANGE: 20021210 FORMER COMPANY: FORMER CONFORMED NAME: ENZON INC DATE OF NAME CHANGE: 19920703 4 1 c68179_form4.xml OWNERSHIP DOCUMENT X0304 4 2012-01-17 0 0000727510 ENZON PHARMACEUTICALS INC ENZN 0001538563 Conover Charles C/O ENZON PHARMACEUTICALS, INC. 20 KINGSBRIDGE ROAD PISCATAWAY NJ 08854 0 1 0 0 SVP, R&D Program Management Common Stock 2012-01-17 4 A 0 10000 0 A 82213 D Common Stock 1158 I By 401(k) plan Employee Stock Option (Right to Buy) 6.69 2012-01-17 4 A 0 25000 0 A 2022-01-17 Common Stock 25000 25000 D Restricted Stock Units granted by the Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock. The Restricted Stock Units will vest in three (3) tranches. Of the 10,000 Restricted Stock Units granted, 3,333 will vest on January 17, 2013, 3,333 will vest on January 17, 2014, and 3,334 will vest on January 17, 2015, in each case if the Reporting Person remains employed by the Issuer on such date. The Restricted Stock Units do not have an expiration date. Includes 3,390 shares of Common Stock beneficially owned through a personal joint account with the Reporting Person's spouse. Options granted by Issuer pursuant to its 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). The options will vest in four (4) tranches. Of the 25,000 options granted, 6,250 options will vest on January 17, 2013, 6,250 options will vest on January 17, 2014, 6,250 options will vest on January 17, 2015, and the remaining 6,250 options will vest on January 17, 2016, in each case if the Reporting Person remains employed by the Issuer on such date. /s/ Andrew Rackear, Attorney-in-Fact 2012-01-19